arrow
S

Sarah Derks

Cancer Center Amsterdam
H指数:24
被引数:2,983

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spatial transcriptomic sequencing identifies lipid metabolism and mitochondrial respiration as central features of T cell excluded esophageal adenocarcinomas

空间转录组测序识别脂质代谢和线粒体呼吸为T细胞排除型食管腺癌的中心特征

2026-10-210
OAAI
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparison

荷兰和比利时食管癌和胃癌患者的治疗与生存:一项基于人群的比较研究

2025-11-010
OAAI
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival

化疗放疗和手术切除后使用阿维单抗辅助治疗食管癌患者:一项真实世界总生存期的配对比较研究

2025-09-230
OAAI
Peritoneal resident macrophages constitute an immunosuppressive environment in peritoneal metastasized colorectal cancer

腹腔固有巨噬细胞构成结直肠癌腹腔转移中的免疫抑制环境

2025-04-171
OA
Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence

欧盟和拉丁美洲国家胃腺癌的免疫分型研究,发现了免疫亚群和微生物组影响方面的全球性差异。

2025-03-200
OA
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes

整合临床变量,放射组学和肿瘤衍生的细胞游离DNA,以增强可切除食管腺癌预后的预测

2025-03-010
OAAI
Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression
2025-01-050
OAAI
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape (vol 27, 649, 2024)
2024-06-170
OAAI
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma

多能性因子NANOG有助于间充质可塑性,并可预测食管腺癌的预后

2024-05-170
OAAI
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape Bertinoro Workshop, November 2022
2024-04-184
OAAI
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations
2024-04-043
OAAI